Treatment Effectiveness
User reported effectiveness ratings Low Dose Naltrexone (LDN) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Back Pain | 20% | 30% | 0% | 40% | 10% | 10 |
| Neck Pain | 0% | 0% | 0% | 100% | 0% | 1 |
| Allergies | 31% | 50% | 0% | 19% | 0% | 16 |
| Crohn's Disease | 67% | 20% | 3% | 10% | 0% | 30 |
| Dandruff | 25% | 25% | 25% | 25% | 0% | 4 |
| Depression | 35% | 29% | 6% | 18% | 12% | 17 |
| Dermatillomania (Compulsive Skin Picking) | 0% | 50% | 0% | 0% | 50% | 2 |
| Food Sensitivity | 67% | 0% | 0% | 33% | 0% | 3 |
| Hypoglycemia | 100% | 0% | 0% | 0% | 0% | 1 |
| Migraine | 30% | 0% | 0% | 60% | 10% | 10 |
| Multiple Chemical Sensitivity (MCS) | 50% | 25% | 0% | 25% | 0% | 4 |
| Multiple Sclerosis | 50% | 32% | 2% | 14% | 3% | 125 |
| Neurological Problems and Chronic Pain | 43% | 19% | 0% | 29% | 10% | 21 |
| Neuropathy | 30% | 20% | 5% | 45% | 0% | 20 |
| Nickel Allergy | 100% | 0% | 0% | 0% | 0% | 1 |
| Night Cramps | 0% | 60% | 20% | 20% | 0% | 5 |
| Osteoarthritis | 20% | 20% | 0% | 60% | 0% | 5 |
| Overactive Bladder | 100% | 0% | 0% | 0% | 0% | 1 |
| Palindromic Rheumatism | 0% | 100% | 0% | 0% | 0% | 1 |
| Premenstrual Syndrome (PMS) | 0% | 25% | 0% | 75% | 0% | 4 |
| Psoriasis | 57% | 29% | 0% | 14% | 0% | 7 |
| Rheumatoid Arthritis | 48% | 48% | 0% | 5% | 0% | 21 |
| Rosacea | 0% | 0% | 0% | 100% | 0% | 1 |
| Ulcerative Colitis | 46% | 23% | 0% | 31% | 0% | 13 |
| Urinary Incontinence | 0% | 33% | 0% | 67% | 0% | 3 |
| Vertigo | 100% | 0% | 0% | 0% | 0% | 1 |
| Vulvar Vestibulitis | 0 | 0 | 0 | 0 | 0 | 0 |
| Fatigue | 27% | 33% | 3% | 28% | 9% | 93 |
| Raynaud's Disease | 17% | 33% | 0% | 33% | 17% | 6 |
| Hashimoto's Disease | 33% | 33% | 11% | 22% | 0% | 9 |
Side Effects
User-reported side effects of Low Dose Naltrexone (LDN)
| Side Effect | Percent of Reports Low Dose Naltrexone (LDN) |
|---|---|
| Hypothyroidism | 5% |
| Body Aches | 23% |
| Difficulty Sleeping | 34% |
| Drowsiness | 25% |
| Increased Self-Confidence | 44% |
| Increased Sense of Well-Being | 55% |
| Increased Sex Drive | 18% |
| Muscle Ache | 23% |
| Sore Joints | 21% |
| Ulcer | 10% |
| Vivid Dreams | 46% |
Outcomes
Below is the degree of change seen after Low Dose Naltrexone (LDN) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Low Dose Naltrexone (LDN) Info
| Property | Value |
|---|---|
| Variable Name | Low Dose Naltrexone (LDN) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-07 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 0.5 |
| Mean | 0.5 count |
| Median | 0.5 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 1 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 1 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 0.70710678118655 |
| Unit | Count |
| User Variables | 1 |
| Variable Category | Treatments |
| Variable ID | 94246 |
| Variance | 0.5 |